Ποια είναι η τιμή για Xvivo Perfusion AB (publ) (XVIVO)

Η τιμή για Xvivo Perfusion AB (publ) (XVIVO) είναι $30.43

Ποια είναι η κεφαλαιοποίηση αγοράς για Xvivo Perfusion AB (publ) (XVIVO)

Η κεφαλαιοποίηση αγοράς για Xvivo Perfusion AB (publ) (XVIVO) είναι $958.38M

Xvivo Perfusion AB (publ) (XVIVO) Τιμή και Κεφαλαιοποίηση Αγοράς

Xvivo Perfusion AB (publ) is a medical technology company that creates and supplies advanced solutions for the preservation and perfusion of organs, tissues, and cells, primarily for use in transplantation. The company's global reach extends across Sweden, the United States, both North and South America, Europe, the Middle East, Africa, and the Asia Pacific region. Its product line includes the XVIVO System (XPS), an integrated, ready-to-use cardiac bypass system designed to facilitate safe normothermic ex vivo lung perfusion (EVLP). To support this, the XPS Disposable Lung Kit offers all the necessary sterile, pre-packed components for EVLP procedures. Xvivo also provides STEEN Solution, an optimally formulated buffered extracellular solution specifically for perfusing isolated donor lungs during EVLP. Additional offerings comprise Perfadex Plus, an extracellular, low-potassium, dextran-based electrolyte preservation solution, and the XVIVO Silicone Tubing Set, used for efficient flushing of donor lungs during the procurement process. The company also manufactures the XVIVO LS and XVIVO Disposable Lung Set, both critical devices for EVLP. Furthermore, Xvivo provides the XVIVO Organ Chamber, a sterile, single-use disposable container for temporarily housing isolated lungs before transplantation, and the XVIVO Lung Cannula Set, another sterile, single-use disposable medical product. Established in 1998, Xvivo Perfusion AB (publ) is headquartered in Gothenburg, Sweden.

Η τιμή για XVIVO	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$167,110 $958.38M	NVDA	$5.264T	+549,145.58%
$149,249 $958.38M	AAPL	$4.701T	+490,443.29%
$132,611 $958.38M	GOOG	$4.177T	+435,757.53%
$121,189 $958.38M	MSFT	$3.817T	+398,217.51%
$90,996.35 $958.38M	AMZN	$2.866T	+298,981.00%

Η τιμή για XVIVO

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$167,110 $958.38M